Immune Senescene Protection Formula by Life Extension — Ingredients, Evidence & Safety

Product Label

Label for Immune Senescene Protection Formula

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Vegetarian Capsule(s) Serving Size

30 Servings

Non-Nutrient/Non-Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Reishi Mushroom (Ganoderma lucidum) extract

980 mg

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews

This product: 980mg

shell-broken Reishi Mushroom

150 mg

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews

This product: 150mg

Cistanche tubulosa extract

210 mg

Other Ingredients

Vegetable Cellulose Rice Flour Starch L-Leucine Silica

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (86% of products) Nutrient (9% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Read the entire label and follow the directions carefully prior to use. DIRECTIONS: Take two (2) capsules daily with food, or as recommended by a healthcare practitioner.

⚠️ Warnings & Precautions

WARNINGS: ~ KEEP OUT OF REACH OF CHILDREN.

~ DO NOT EXCEED RECOMMENDED DOSE. ~ Do not purchase if outer seal is broken or damaged.

~ When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

🧪 Formulation Notes

Standardized Cistanche and Reishi

Non-GMO

Additional Information

Support for the Aging Immune System*

To report a serious adverse event or obtain product information, contact 1-866-280-2852.

Scan for product info

Q01905B

Store tightly closed in a cool, dry place.

Product Details

UPC / SKU 7 37870 19056 1

DSLD Entry Date 2016-06-24

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Life Extension

DSLD ID 60843

Data Updated 2026-04-11

Research Evidence

6 Research Sources

60 Avg Quality Score

3 Meta Analysis

3 Rct

B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients

Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021

PubMed DOI

C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India

Rct International journal of medicinal mushrooms 2024

PubMed DOI

C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

Rct Integrative cancer therapies 2020

PubMed DOI

View all evidence for Reishi →